Change in Body Mass Index and Attributable Risk of New-Onset Hypertension Among Obese Living Kidney Donors

Objective: To examine whether body mass index (BMI) changes modify the association between kidney donation and incident hypertension. Background: Obesity increases hypertension risk in both general and living kidney donor (LKD) populations. Donation-attributable risk in the context of obesity, and whether weight change modifies that risk, is unknown. Methods: Nested case-control study among 1558 adult LKDs (1976–2020) with obesity (median follow-up: 3.6 years; interquartile range: 2.0–9.4) and 3783 adults with obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) and Atherosclerosis Risk in Communities (ARIC) studies (9.2 y; interquartile range: 5.3–15.8). Hypertension incidence was compared by donor status using conditional logistic regression, with BMI change investigated for effect modification. Results: Overall, LKDs and nondonors had similar hypertension incidence [incidence rate ratio (IRR): 1.16, 95% confidence interval (95% CI): 0.94–1.43, P=0.16], even after adjusting for BMI change (IRR: 1.25, 95% CI: 0.99–1.58, P=0.05). Although LKDs and nondonors who lost >5% BMI had comparable hypertension incidence (IRR: 0.78, 95% CI: 0.46–1.34, P=0.36), there was a significant interaction between donor and >5% BMI gain (multiplicative interaction IRR: 1.62, 95% CI: 1.15–2.29, P=0.006; relative excess risk due to interaction: 0.90, 95% CI: 0.24–1.56, P=0.007), such that LKDs who gained weight had higher hypertension incidence than similar nondonors (IRR: 1.83, 95% CI: 1.32–2.53, P<0.001). Conclusions: Overall, LKDs and nondonors with obesity had similar hypertension incidence. Weight stability and loss were associated with similar hypertension incidence by donor status. However, LKDs who gained >5% saw increased hypertension incidence versus similar nondonors, providing support for counseling potential LKDs with obesity on weight management postdonation.

[1]  A. Matas,et al.  Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors , 2021, Journal of the American Society of Nephrology : JASN.

[2]  J. Kai,et al.  Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK , 2021, BMC Public Health.

[3]  T. Cole,et al.  Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: A cohort study , 2020, PLoS medicine.

[4]  M. Ikram,et al.  Do Case-Control Studies Always Estimate Odds Ratios? , 2020, American journal of epidemiology.

[5]  Craig M. Hales,et al.  Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. , 2020, NCHS data brief.

[6]  R. Reed,et al.  Patient Perspectives on Weight Management for Living Kidney Donation. , 2019, The Journal of surgical research.

[7]  A. Garg,et al.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records , 2019, Clinical transplantation.

[8]  J. Friedewald,et al.  Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[9]  D. Segev,et al.  Early Hypertension and Diabetes after Living Kidney Donation: A National Cohort Study. , 2019, Transplantation.

[10]  Edward G. Clark,et al.  Changes in Body Weight Before and After Kidney Donation , 2019, Canadian journal of kidney health and disease.

[11]  A. Matas,et al.  Implications of excess weight on kidney donation: Long‐term consequences of donor nephrectomy in obese donors , 2018, Surgery.

[12]  D. Segev,et al.  Racial differences in completion of the living kidney donor evaluation process , 2018, Clinical transplantation.

[13]  B. Kasiske,et al.  Temporal trends, center‐level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Tanjala S. Purnell,et al.  The National Landscape of Living Kidney Donor Follow‐Up in the United States , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  A. Israni,et al.  The Living Donor Collective: A Scientific Registry for Living Donors , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  A. Garg,et al.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors , 2017, Transplantation.

[17]  C. Lewis,et al.  Obesity increases the risk of end-stage renal disease among living kidney donors. , 2017, Kidney international.

[18]  C. Lewis,et al.  Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors , 2017, Annals of surgery.

[19]  J. Poorolajal,et al.  How much excess weight loss can reduce the risk of hypertension? , 2016, Journal of public health.

[20]  R. Plodkowski,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[21]  L. F. Junqueira,et al.  Male Gender and Body Mass Index Are Associated With Hypertension and Reduced Kidney Function 5 or More Years After Living Kidney Donation. , 2015, Transplantation proceedings.

[22]  J. Schold,et al.  Critical Factors Associated With Missing Follow‐Up Data for Living Kidney Donors in the United States , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  M. Gulliford,et al.  Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. , 2015, American journal of public health.

[24]  Tyler J. VanderWeele,et al.  A Tutorial on Interaction , 2014 .

[25]  A. Garg,et al.  Understanding Antihypertensive Medication Use after Living Kidney Donation through Linked National Registry and Pharmacy Claims Data , 2014, American Journal of Nephrology.

[26]  S. Saydah,et al.  Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999‐2010 , 2014, Obesity.

[27]  F. Hu,et al.  Executive summary: Guidelines (2013) for the management of overweight and obesity in adults , 2014, Obesity.

[28]  A. Garg,et al.  Medical Outcomes in African American Live Kidney Donors: A Matched Cohort Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  S. Mulgaonkar,et al.  Racial Differences in Outcomes of the Evaluation of Potential Live Kidney Donors: A Retrospective Cohort Study , 2012, American Journal of Nephrology.

[30]  T. Sairenchi,et al.  Long-term stable obesity increases risk of hypertension , 2011, International Journal of Obesity.

[31]  M. Schnitzler,et al.  Racial variation in medical outcomes among living kidney donors. , 2010, The New England journal of medicine.

[32]  A. Matas,et al.  Diabetes after Kidney Donation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  H. Assadi,et al.  Long-term renal function and cardiovascular disease risk in obese kidney donors. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[34]  W. Weimar,et al.  Long-term consequences of kidney donation. , 2009, The New England journal of medicine.

[35]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[36]  Paul T. Williams Increases in Weight and Body Size Increase the Odds for Hypertension During 7 Years of Follow‐up , 2008, Obesity.

[37]  J. Stevens,et al.  Effect of 3‐Year Weight History on Blood Pressure: The Atherosclerosis Risk in Communities Study , 2008, Obesity.

[38]  M. Ghoneim,et al.  Long‐term follow‐up of living kidney donors: a longitudinal study , 2007, BJU international.

[39]  R. D'Agostino,et al.  Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. , 2005, Archives of internal medicine.

[40]  D. Levy,et al.  Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression , 2005, Circulation.

[41]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[42]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[43]  K. Ishikawa-Takata,et al.  Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men , 2002, European Journal of Clinical Nutrition.

[44]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[45]  I. Okosun,et al.  Abdominal obesity in the United States: prevalence and attributable risk of hypertension , 1999, Journal of Human Hypertension.

[46]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[47]  W. Kannel,et al.  The relation of adiposity to blood pressure and development of hypertension. The Framingham study. , 1967, Annals of internal medicine.

[48]  P. MacLennan,et al.  Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up , 2018, Transplantation.

[49]  W. Rosamond,et al.  Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study , 2002, International Journal of Obesity.

[50]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.